Evidence map›Paper›PMID 41678259›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2026

Removal of volatile organic compounds by chemical filters significantly inhibited the development of atopic dermatitis symptoms in mice: potential implications for air-conditioning systems in healthcare environments.

Chiharu Ohira, Kengo Tomita, Yukiko Ota, Keiichi Yano, Mona Amano, Mao Kaneki, Atsushi Yamada, Riku Usui, Yuzo Nagai, Masaki Nagane and 2 more

Abstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chiharu OhiraLaboratory of Veterinary Pharmacology, School of Veterinary Medicine, Azabu University, Sagamihara-shi, Kanagawa 252-5201, Japan.
Kengo TomitaInstitute of Technology, Shimizu Corporation, Koto-ku, Tokyo 135-8530, Japan.
Yukiko OtaInstitute of Technology, Shimizu Corporation, Koto-ku, Tokyo 135-8530, Japan.
Keiichi YanoInstitute of Technology, Shimizu Corporation, Koto-ku, Tokyo 135-8530, Japan.
Mona AmanoInstitute of Technology, Shimizu Corporation, Koto-ku, Tokyo 135-8530, Japan.
Mao KanekiLaboratory of Veterinary Pharmacology, School of Veterinary Medicine, Azabu University, Sagamihara-shi, Kanagawa 252-5201, Japan.
Atsushi YamadaCommercial Product Planning & Development Department, Fuji Industrial Co., Ltd., Sagamihara-shi, Kanagawa, 252-0206, Japan.
Riku UsuiCommercial Product Planning & Development Department, Fuji Industrial Co., Ltd., Sagamihara-shi, Kanagawa, 252-0206, Japan.
Yuzo NagaiCommercial Product Planning & Development Department, Fuji Industrial Co., Ltd., Sagamihara-shi, Kanagawa, 252-0206, Japan.
Masaki NaganeLaboratory of Biochemistry, School of Veterinary Medicine, Azabu University, Sagamihara-shi, Kanagawa 252-5201, Japan.ORCID 0000-0002-3408-7656
Satoshi TakagiLaboratory of Small Animal Surgery, School of Veterinary Medicine, Azabu University, Sagamihara-shi, Kanagawa 252-5201, Japan.
Tomoki FukuyamaLaboratory of Veterinary Pharmacology, School of Veterinary Medicine, Azabu University, Sagamihara-shi, Kanagawa 252-5201, Japan.ORCID 0000-0003-3510-3272

Funding

Shimizu Corporation, 3-4-17 Etchujima, Koto-ku, Tokyo 135-8530, Japan
6 · The paper itself

Abstract

Volatile organic compounds (VOCs) are increasingly implicated in systemic diseases, but their contribution to skin disorders such as atopic dermatitis (AD) remains unclear. This study assessed VOC concentrations in medical environments, their effects on AD development, and the efficacy of VOC removal using chemical filters. Total VOC levels were monitored in 3 types of veterinary hospitals. AD-like lesions were induced in female NC/Nga mice by repeated dermal application of toluene diisocyanate or house dust mite ointment, with or without topical exposure to a VOC mixture (10 μg/ml). Clinical parameters, including dermatitis scores, transepidermal water loss, and skin thickness, were measured weekly, and immunological and histological analyses were performed. VOC monitoring revealed that 1 hospital exhibited concentrations exceeding 400 μg/m³. In the mouse model, direct VOC exposure significantly aggravated keratinocyte inflammation and worsened AD symptoms. Application of chemical filtering systems effectively reduced VOC levels in real clinical settings, and their use in the experimental model suppressed AD development. However, therapeutic application of VOC removal showed only limited effects on systemic immunological markers. These findings suggest that VOCs present in healthcare environments may contribute to the onset and progression of AD. Incorporating VOC-removing filters into air-conditioning systems could serve as a preventive strategy to improve the management of allergic skin diseases.

Indexed as

Air FiltersAir Pollution, IndoorDermatitis, AtopicFiltrationVolatile Organic CompoundsAnimalsDisease Models, AnimalFemaleMiceSkinToluene 2,4-DiisocyanateToluene 2,4-DiisocyanateVolatile Organic Compoundsair filtrationatopic dermatitiskeratinocytemouse modelvolatile organic compounds

Identifiers

PMID41678259
PMCPMC13017123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.